Explore how the Hatch-Waxman Act revolutionized the pharmaceutical industry by enabling generic drug approvals through the ANDA process while protecting brand-name patents. Learn about its impact on drug prices and current controversies.
Read Details
Explore how antitrust laws fight 'pay-for-delay' and product hopping to ensure generic drug competition and lower medication costs for patients.
Read Details
The Federal Circuit Court controls all U.S. pharmaceutical patent appeals, shaping when generics can launch, how patents are challenged, and ultimately, drug prices. Its rulings on ANDA jurisdiction, dosing patents, and standing have transformed the industry.
Read Details
